Comparison of platinum combination chemotherapy plus pembrolizumab versus platinum combination chemotherapy plus nivolumab–ipilimumab for treatment-naive advanced non-small-cell lung cancer in Japan (JCOG2007): an open-label, multicentre, randomised, phase 3 trialYoshimasa Shiraishi, Isamu Okamoto, Shogo Nomura et al.|The Lancet Respiratory Medicine|2024Cited by 43
Protocol digest of a phase III randomized trial of gross total resection versus possible resection of fluid-attenuated inversion recovery-hyperintense lesion on MRI for newly diagnosed supratentorial glioblastoma: JCOG2209 (FLAMINGO)Yuta Sekino, Yoshitaka Narita, Toshihiro Kumabe et al.|Japanese Journal of Clinical Oncology|2024Cited by 3
Randomized phase III trial of neo-adjuvant and adjuvant chemotherapy vs adjuvant chemotherapy alone for localized soft tissue sarcoma (NACLESS, JCOG2102).Yuki Funauchi, Satoshi Tsukushi, Hiroaki Hiraga et al.|Journal of Clinical Oncology|2024Cited by 0
AB012. A phase III randomized trial of gross total resection versus possible resection of fluid-attenuated inversion recovery (FLAIR) hyperintensity lesion on magnetic resonance image for newly diagnosed supratentorial glioblastoma (JCOG2209)Yukihiko Sonoda, Yoshitaka Narita, Yuta Sekino et al.|Chinese Clinical Oncology|2024Cited by 0
SURG-08. A PHASE III RANDOMIZED TRIAL OF GROSS TOTAL RESECTION VERSUS POSSIBLE RESECTION OF FLAIR HYPERINTENSITY LESION ON MR IMAGE FOR NEWLY DIAGNOSED SUPRATENTORIAL GLIOBLASTOMA (JCOG2209)Yukihiko Sonoda, Yoshitaka Narita, Yuta Sekino et al.|Neuro-Oncology|2024Cited by 0